Evaluating Ubrogepant's Impact on Migraine Prodrome Outcomes

This chapter explores a study on Ubrogepant, a migraine treatment, examining its positive effects on patient-reported outcomes during the prodrome phase. The findings reveal significant improvements in functioning, reduced disability, and increased patient satisfaction compared to a placebo.